Unlocking the clinical trial potential of "New Markets"

Notable in all of these countries is a naïve population, highly motivated to participate in trials. Vast improvements in standards of medical care is another positive common factor, along with pools of highly educated medical workers all of which creates an environment supportive to clinical trials.

Georgia has the fastest regulatory approval times in Eastern Europe; Uzbekistan's rapidly-growing population means increasing consumer demand for pharmaceuticals..

In terms of logistics, there are all sorts of practical challenges to overcome – the sheer size of territories, or certain weather conditions. The strength of some countries lies in transportation and storage of medicines. In others, it's warehouse capabilities – all of these factors are being examined.

However, to fully tap into the potential of these markets, careful, bespoke organisation is needed. The requirements for Georgia, Armenia and Azerbaijan in terms of project management differ from those in Central Asia – COREX has already identified approaches to deal effectively with these differences.

There are many factors to be taken into consideration when laying foundations for the future in these new territories, not least economics, government involvement and response from the public.

However, The COREX Logistics team believes that these regions have a high potential for clinical trials and that there are positive times ahead. If you’d like to read about our view of New Markets for clinical trials in more detail, including the views of the COREX team, then download our free White Paper on the subject.